https://stock.noler.com/us/stock/sio-gene-therapies-inc https://stock.noler.com/us/stock/sio-gene-therapies-inc/accounts-payable https://stock.noler.com/us/stock/sio-gene-therapies-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/accrued-liabilities-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/sio-gene-therapies-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/sio-gene-therapies-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/basic-shares https://stock.noler.com/us/stock/sio-gene-therapies-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/sio-gene-therapies-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/sio-gene-therapies-inc/cash-and-equivalents https://stock.noler.com/us/stock/sio-gene-therapies-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/sio-gene-therapies-inc/cash-flow-breakdown https://stock.noler.com/us/stock/sio-gene-therapies-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/sio-gene-therapies-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sio-gene-therapies-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/sio-gene-therapies-inc/common-stock-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/comprehensive-income https://stock.noler.com/us/stock/sio-gene-therapies-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/sio-gene-therapies-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/sio-gene-therapies-inc/current-assets https://stock.noler.com/us/stock/sio-gene-therapies-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/sio-gene-therapies-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/sio-gene-therapies-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/sio-gene-therapies-inc/current-liabilities https://stock.noler.com/us/stock/sio-gene-therapies-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-carrying-amount https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-fair-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-issued https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-repaid https://stock.noler.com/us/stock/sio-gene-therapies-inc/debt-unamortized-discount-premium-and-debt-issuance-costs-net https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-offering-costs https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-liabilities-net-noncurrent https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/sio-gene-therapies-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/sio-gene-therapies-inc/depreciation-and-amortization https://stock.noler.com/us/stock/sio-gene-therapies-inc/diluted-shares https://stock.noler.com/us/stock/sio-gene-therapies-inc/due-to-related-parties-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/sio-gene-therapies-inc/effective-tax-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/eps https://stock.noler.com/us/stock/sio-gene-therapies-inc/eps-basic https://stock.noler.com/us/stock/sio-gene-therapies-inc/equity-securities-without-readily-determinable-fair-value-amount https://stock.noler.com/us/stock/sio-gene-therapies-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/sio-gene-therapies-inc/financing-cash-flow https://stock.noler.com/us/stock/sio-gene-therapies-inc/foreign-pretax-income https://stock.noler.com/us/stock/sio-gene-therapies-inc/gain-loss-on-investments https://stock.noler.com/us/stock/sio-gene-therapies-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/sio-gene-therapies-inc/general-and-administrative-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/income-tax https://stock.noler.com/us/stock/sio-gene-therapies-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/income-taxes-paid https://stock.noler.com/us/stock/sio-gene-therapies-inc/income-taxes-receivable https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-other-accounts-payable https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/sio-gene-therapies-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/sio-gene-therapies-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/sio-gene-therapies-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/sio-gene-therapies-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/sio-gene-therapies-inc/interest-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/interest-paid https://stock.noler.com/us/stock/sio-gene-therapies-inc/interest-paid-net https://stock.noler.com/us/stock/sio-gene-therapies-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/sio-gene-therapies-inc/investing-cash-flow https://stock.noler.com/us/stock/sio-gene-therapies-inc/lease-and-rental-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sio-gene-therapies-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/sio-gene-therapies-inc/long-term-debt https://stock.noler.com/us/stock/sio-gene-therapies-inc/long-term-debt-maturing-in-years-four-and-five https://stock.noler.com/us/stock/sio-gene-therapies-inc/long-term-debt-maturing-in-years-two-and-three https://stock.noler.com/us/stock/sio-gene-therapies-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/sio-gene-therapies-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/sio-gene-therapies-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/sio-gene-therapies-inc/net-change-in-cash https://stock.noler.com/us/stock/sio-gene-therapies-inc/net-income https://stock.noler.com/us/stock/sio-gene-therapies-inc/nonmonetary-transaction-gain-loss-recognized-on-transfer https://stock.noler.com/us/stock/sio-gene-therapies-inc/number-of-operating-segments https://stock.noler.com/us/stock/sio-gene-therapies-inc/number-of-reportable-segments https://stock.noler.com/us/stock/sio-gene-therapies-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/sio-gene-therapies-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/sio-gene-therapies-inc/oci-net-of-tax https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-cash-flow https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-expenses https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-income https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-assets https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-liability https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-liability-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-in-four-and-five-years https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-in-two-and-three-years https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/sio-gene-therapies-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/sio-gene-therapies-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/other-income https://stock.noler.com/us/stock/sio-gene-therapies-inc/other-noncash-income-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/other-noncurrent-assets https://stock.noler.com/us/stock/sio-gene-therapies-inc/other-nonoperating-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/paid-in-capital-other https://stock.noler.com/us/stock/sio-gene-therapies-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/sio-gene-therapies-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/sio-gene-therapies-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/sio-gene-therapies-inc/payment-of-financing-and-stock-issuance-costs https://stock.noler.com/us/stock/sio-gene-therapies-inc/payments-for-restructuring https://stock.noler.com/us/stock/sio-gene-therapies-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/sio-gene-therapies-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/sio-gene-therapies-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/sio-gene-therapies-inc/preferred-shares-facts https://stock.noler.com/us/stock/sio-gene-therapies-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/sio-gene-therapies-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/sio-gene-therapies-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/pretax-income https://stock.noler.com/us/stock/sio-gene-therapies-inc/pretax-income-domestic https://stock.noler.com/us/stock/sio-gene-therapies-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/sio-gene-therapies-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/sio-gene-therapies-inc/proceeds-from-sale-of-longterm-investments https://stock.noler.com/us/stock/sio-gene-therapies-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/sio-gene-therapies-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/sio-gene-therapies-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/sio-gene-therapies-inc/property-plant-equipment https://stock.noler.com/us/stock/sio-gene-therapies-inc/public-float https://stock.noler.com/us/stock/sio-gene-therapies-inc/research-and-development https://stock.noler.com/us/stock/sio-gene-therapies-inc/research-and-development-in-process https://stock.noler.com/us/stock/sio-gene-therapies-inc/restricted-cash-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/sio-gene-therapies-inc/restructuring-charges https://stock.noler.com/us/stock/sio-gene-therapies-inc/restructuring-reserve https://stock.noler.com/us/stock/sio-gene-therapies-inc/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/sio-gene-therapies-inc/retained-earnings https://stock.noler.com/us/stock/sio-gene-therapies-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/sio-gene-therapies-inc/severance-costs https://stock.noler.com/us/stock/sio-gene-therapies-inc/shareholders-equity https://stock.noler.com/us/stock/sio-gene-therapies-inc/shares-authorized https://stock.noler.com/us/stock/sio-gene-therapies-inc/shares-issued https://stock.noler.com/us/stock/sio-gene-therapies-inc/short-term-investments https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-award-accelerated-vesting-number https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-based-compensation https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/sio-gene-therapies-inc/stock-split-ratio https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/sio-gene-therapies-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/sio-gene-therapies-inc/taxes-payable-current https://stock.noler.com/us/stock/sio-gene-therapies-inc/total-assets https://stock.noler.com/us/stock/sio-gene-therapies-inc/total-liabilities https://stock.noler.com/us/stock/sio-gene-therapies-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/sio-gene-therapies-inc/total-long-term-debt https://stock.noler.com/us/stock/sio-gene-therapies-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/sio-gene-therapies-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/sio-gene-therapies-inc/weighted-average-number-of-share-outstanding-basic-and-diluted